ARCpoint (ARC.V) Stock Price

ARCpoint, Inc. generates revenue through its franchise system, which includes drug testing, alcohol screening, DNA, and clinical lab testing services. The ARCpoint Franchise segment sells franchises to individuals across the United States, providing marketing, technology, and training support. The AFG Services segment offers clinical testing, software services, and diagnostic testing kits to franchisees and other business-to-business customers. The Other segment operates corporate-owned labs that serve businesses, physicians, and customers directly. Revenue streams include franchise fees, sales of diagnostic kits, and corporate lab services. ARCpoint Franchise segment revenue comes from franchise sales and ongoing support services. AFG Services segment revenue is derived from clinical testing, software services, and direct sales of diagnostic kits to business customers. Corporate-owned labs in the Other segment provide clinical and diagnostic services to businesses, physicians, and end customers, contributing to overall revenue. The company's business model relies on a mix of franchise sales, service offerings, and direct B2B transactions. The company's primary customers are individuals purchasing franchises, businesses requiring clinical testing, and physicians seeking diagnostic services. Franchisees benefit from ARCpoint's marketing, technology, and training support. AFG Services targets businesses needing diagnostic kits and software solutions. Corporate-owned labs serve businesses, physicians, and end customers with comprehensive testing solutions. Revenue is generated through multiple channels within the company's segmented structure.